Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market

–Forecast to 2024

Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global

Market estimated to be worth $1,447.3 million by 2024

IQ4I Research & Consultancy published a new report on “Cardiac Electrophysiology

Mapping, Navigation and Recording Devices Global Market – Forecast To 2024” This
report analyzes and studies the overall market, major Drivers & Opportunities, Restraints &
Threats in North America, Europe, Asia-Pacific and Rest of the World.

IQ4I’s Report Contains 62 market data tables and 60 figures spread through 253 pages
and an exhaustive TOC on “Cardiac Electrophysiology Mapping, Navigation and
Recording Devices Global Market”, [Products (Mapping and Navigation Systems (Contact
Mapping Systems, Non Contact Mapping Systems), Mapping and Navigation Catheters,
Recording Systems and Accessories); End-Users (Hospitals, Cardiac Centers/ASCs, Other
End-User); Region (North America, Europe, Asia-Pacific and Rest of the World)]

Arrhythmia refers to the irregular rhythm of the heartbeat due to any minute changes in the
electrical impulses of the heart. The different types of Arrhythmia are tachycardia,
bradycardia, Atrial fibrillation and ventricular fibrillation. The main causes of arrhythmia are
high blood pressure, diabetes, heart attack, heart valve disease, coronary artery disease,
and cardiomyopathy. Cardiac electrophysiology (EP) mapping, navigation and recording
medical devices have been employed to aid in the guidance of curative diagnostic
procedures for the treatment of cardiac arrhythmias that cannot be sufficiently characterized
with more conventional methodologies. Technological advancements, improved success,
and fewer complications led to widespread acceptance of Cardiac EP mapping, navigation
and recording devices. As estimated by IQ4I Research that the Cardiac EP mapping,
navigation and recording devices global market is expected to grow at a high single digit
CAGR to reach $1,447.3 million by 2024. Increasing number of patients with arrhythmia,
increase in geriatric population with more chronic disorders, increase in minimally invasive
technologies for atrial fibrillation are some of the drivers of the market. Increase in research
and development activities, emergence of new technologies are some of the opportunities
that are propelling the growth of the market. However, inaccuracy of the imaging systems
due to body movements, high cost of devices, exposure to harmful radiations from the
devices are some of the restraints of the market. Stringent regulatory requirements and
availability of alternative products are some of the threats of the market.

The Cardiac EP mapping, navigation and recording devices global market by products is
segmented into mapping and navigation systems, mapping and navigation catheters,
recording systems and accessories. Electrophysiology mapping and navigation systems

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market

–Forecast to 2024

market by mapping type is segmented into contact mapping systems and non contact
mapping systems. Among the products, recording systems holds the highest share in 2017
and expected to grow at a medium single digit CAGR from 2017 to 2024 due to emergence
of new technologies and also due to the accuracy and efficiency of the recording systems.
Among the former segment contact mapping holds the highest share in 2017 and expected
to grow at a high single digit CAGR from 2017 to 2024.

Among the products with respect to fastest growing segment, mapping and navigation
catheters are expected to grow at a strong double digit CAGR from 2017 to 2024. Major
companies are adopting approval strategy in the expansion of Cardiac EP mapping,
navigation and recording devices product portfolio, for instance in Jan 2018, Abbott
Laboratories (St. Jude medical) (U.S.) received CE Mark approval for the company's new
Advisor HD Grid Mapping Catheter, a product designed to advance cardiac
mapping during cardiac ablation. Similarly, Medtronic plc (Ireland) has received U.S. Food
and Drug Administration (FDA) 510(k) clearance for the CardioInsight Noninvasive 3D
Mapping System. The CardioInsight system is used to map a wide range of irregular heart
rhythms.

The global leaders in the electrophysiology are establishing a strong foothold in the market
with the strong patented portfolio, geographical presence, developing differentiated
advanced and innovative technology, new product launches and improved sales network.
For instance, Boston Scientific launched the Rhythmia mapping system which compared to
the previous generation mapping systems can show lower voltages. It uses a 64-electrode
basket catheter to generate, high-density electro-maps with approximately 50,000 to 60,000
points. The Rhythmia mapping system gives more accurate mapping, more points, clearer
electrograms resulting in better efficacy for the patients it is one of the technological
advancements that are going to drive the cardiac EP market in coming years.

The EP cardiac mapping, navigation and recording devices by end-users is segmented into
hospitals, cardiac centers with electrophysiology and ambulatory surgical centers, academic
and research institutes. According to IQ4I estimation the end users market is expected to
grow at a high single digit CAGR from 2017 to 2024. Improved patient safety and clinical
outcomes and reducing diagnosis error drive the end users market. High cost of devices and
lack of skilled electrophysicians hampers the market.

The Cardiac EP mapping, navigation and recording devices global market based on
geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market

–Forecast to 2024

American region commanded the largest revenue in 2017 and expected to grow at a high
single digit CAGR from 2017 to 2024. Increasing atrial fibrillation procedures, growth in aging
population and significant increase in cardiac centers in U.S. has led the market growth in
this region. However, Asia-Pacific is expected to grow at a high CAGR from 2017 to 2024
owing to the rapidly increasing aging population and rise in healthcare awareness in the
emerging countries, such as India and China.

The dominant players are using acquisitions, collaborations and new product launches as
their core strategy to strengthen their position in the market. For instance, in May 2018
Stereotaxis Inc, (U.S.) and Acutus Medical (U.S.) entered into strategic collaboration to
integrate the Stereotaxis Niobe Magnetic Navigation System and the Acutus Medical
AcQMap High Resolution Imaging and Mapping System to improve patient care and
physician experience in electrophysiology.

Availability of alternative products and with technological innovations occurring at a rapid

pace in the electrophysiology market patients prefer to employ treatments which have more
success rates, lower risk of complications and lesser turnaround time, pose challenges to
the EP market. For instance iMRIcore is developing medical devices to perform MRI guided
ablation procedures that can give the image of soft tissues without being exposed to
radiation, eliminating the need of wearing heavy protective aprons also allowing the
electrophysicians to give pattern and effectiveness of ablation points.

Companies such as Johnson and Johnson, Medtronic, Abbott Laboratories and Boston
Scientific are ahead of other companies are considered to be leaders in this space with their
marketed products and strong pipe liners. Johnson and Johnson (Biosense Webster) is a
leader in Cardiac EP mapping, navigation and recording devices market and holds the
highest market share. The company’s core strength is its unique CARTO 3 mapping system
which is an advanced imaging technology that utilizes electromagnetic technology to create
real-time three-dimensional (3D) maps of a patient’s cardiac structures. Followed by Abbott
Laboratories (St. Jude Medical) is a leader in Cardiac EP mapping, navigation and recording
devices market and holds the second highest market share. Abbott’s core strength is its
Ensite Presicion mapping system and its broad range of mapping catheters each of which is
highly compatible with the Ensite Presicion and Ensite Velocity mapping system.

The Cardiac EP mapping, navigation and recording devices global market is a consolidated
market with top five players occupying major market share and the remaining players

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market

–Forecast to 2024

occupied low market share. The existing players in this market are involved in developing
new and advanced products to maintain their market shares. For instance, in July 2016 Auris
Surgical Robotics, Inc. completed acquisition of Hansen Medical, with this acquisition Auris
Surgical Robotics, Inc. has a diversified product portfolio in advanced medical robotics in
electrophysiology.

Major players in the Cardiac EP mapping, navigation and recording devices global market
are Abbott Laboratories (St Jude Medical) (U.S.), Boston Scientific (U.S.), Johnson
&Johnson (U.S.) (Biosense Webster), Medtronic PLC. (Ireland), Stereotaxis, Inc. (U.S.),
Acutus Medical (U.S.), GE Healthcare (U.S.), Auris Surgical Robotics (Hansen Medical),
Microport Scientific Corporation (China), Magnetecs Corporation (U.S.).

APN Health (U.S.), Kardium (U.S.), EP Solutions (Switzerland), Pulmokard Gmbh

(Germany) are some of the emerging players in the Cardiac EP mapping, navigation and
recording devices market.

IQ4I Research & Consultancy Pvt. Ltd. Page 4

Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market

–Forecast to 2024

Reasons for buying this report:

 Cardiac EP mapping, navigation and recording devices global market is expected to

reach $1,447.3 million by 2024 at a CAGR of 6.6%.
 Identification and analysis of the Cardiac EP mapping, navigation and recording
devices market by identifying various segments by product, product type, end-users
and geography.
 Revenue forecast of Cardiac EP mapping, navigation and recording devices market
and strategic analysis of each sub-segment with respect to segmental growth trends.
 Identification of major market trends, Porter's model, and factors driving and
restraining Cardiac EP mapping, navigation and recording devices market growth.
 Market penetration, product matrix, no. of units and installed base of Cardiac
electrophysiology mapping, navigation and recording devices.
 Procedure volume data of Cardiac EP mapping and navigation catheters.
 Revenue forecast of the Cardiac EP mapping, navigation and recording devices
market with respect to North America, Europe, Asia-Pacific and Rest of the World
(RoW) regions.
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Identification of key technology developments and innovations driving the market.
 Market share analysis of global market, individual market share analysis of EP
mapping navigation systems and recording systems, patent and supply chain of the
Cardiac EP mapping, navigation and recording devices market by major players.
 Profiles of major players in Cardiac EP mapping, navigation and recording devices
market and analysis of their product offerings, financial revenue, business strategies,
SWOTs.

IQ4I Research & Consultancy Pvt. Ltd. Page 5

Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market

–Forecast to 2024

FIGURE 1

CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES

GLOBAL MARKET SEGMENTATION

Cardiac EP Mapping, Navigation and Recording

Devices Global Market

Products End-users Region

EP M and N
Hospitals NA EU APAC ROW
Devices

Cardiac
Contact U.S. Germany Japan Brazil
Centers/Asc’s

Rest of
Non-Contact Others Others U.K. China
LATAM

EP Recording Middle East

France India
Systems and Others

EP M and N
Others Others
Catheters

Accessories

Source: World Health Organization (WHO), Cardiac Electrophysiology Society (CES), British Heart Rhythm
Society (BHRS), European Cardiac Arrhythmia Society (ECAS), European Heart Rhythm Association (EHRA),
Canadian Heart Rhythm Society (CHRS), Cardiac Arrhythmia Network of Canada (CANet), Japanese Heart
Rhythm Society (JHRS), American Heart Association (AHA), Industrial Experts and IQ4I Analysis.

IQ4I Research & Consultancy Pvt. Ltd. Page 6